Inclusive clinical studies for equitable access to clinical research in Europe

The "Inclusive Clinical Studies" program targets a broad range of entities within Europe focused on health research, aiming to improve patient diversity and access in clinical trials. It encourages collaboration among researchers, industry, healthcare providers, and patient organizations to foster more equitable and representative clinical research landscapes.

The program supports research and innovation actions focused on overcoming barriers in clinical study participation, particularly for underserved populations. Projects should develop and test practical solutions, tools, and best practices to improve recruitment, retention, and overall inclusivity across various health technology domains.

Funding is provided through grants for research and innovation actions, with a significant contribution expected from industry partners. The maximum funding per project for this specific topic is €33,000,000, and proposals are evaluated through a two-stage process.

Applicants must adhere to specific conditions regarding proposal submission, consortium formation, and financial contributions. The program emphasizes a collaborative approach and compliance with general Horizon Europe rules and IHI-specific requirements.

The application process for this program follows a two-stage procedure, requiring detailed proposals and specific annexes to be submitted through the IT system. Evaluation is based on defined criteria, with indicative timelines provided for assessment and grant agreement finalization.

The program operates under the robust legal framework of Horizon Europe and specific regulations governing Joint Undertakings, ensuring a transparent and structured funding environment.